High-Intensity Focused Ultrasonography and Radiofrequency Ablation of Renal Cell Carcinoma Arisen in Transplanted Kidneys: Single-Center Experience With Long-Term Follow-Up and Review of Literature.
Adult
Carcinoma, Renal Cell
/ diagnostic imaging
Female
Follow-Up Studies
High-Intensity Focused Ultrasound Ablation
/ methods
Humans
Kidney
/ diagnostic imaging
Kidney Neoplasms
/ diagnostic imaging
Kidney Transplantation
Male
Middle Aged
Retrospective Studies
Treatment Outcome
Ultrasonography, Interventional
/ methods
HIFU
RF
ablative techniques
renal cell carcinoma
transplanted kidney
Journal
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
ISSN: 1550-9613
Titre abrégé: J Ultrasound Med
Pays: England
ID NLM: 8211547
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
21
06
2018
revised:
06
11
2018
accepted:
19
12
2018
pubmed:
29
1
2019
medline:
11
2
2020
entrez:
29
1
2019
Statut:
ppublish
Résumé
The purpose of this article is to retrospectively evaluate the long-term outcome of patients treated with percutaneous thermoablation for renal cell carcinomas that have arisen in kidney grafts. Between April 2008 and February 2011, we treated 3 patients with renal cell carcinoma on a transplanted kidney: 2 cases were treated with high-intensity focused ultrasonography and 1 patient with radio frequency ablation. Postprocedural ultrasonography did not reveal any complications, and contrast-enhanced ultrasonography showed an avascular area in the treated nodules. None of the patients had recurrent tumors during a long-term clinical and radiologic follow-up (81, 73, and 43 months, respectively).
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2507-2513Informations de copyright
© 2019 by the American Institute of Ultrasound in Medicine.
Références
Hourmant M, Garandeau C. The evolution of kidney transplantation over the last 20 years. Presse Med 2011; 40:1074-1080.
Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306:1891-1901.
Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905-913.
Krapp JD, Brauer RB, Matevossian E, et al. Donor transmitted anaplastic carcinoma in a kidney-transplant recipient. Transpl Int 2005; 18:1109-1112.
Barama A, St-Louis G, Nicolet V, Hadjeres R, Daloze P. Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 2005; 5:3015-3018.
Su MZ, Campbell NA, Lau HM. Management of renal masses in transplant allografts at an Australian kidney-pancreas transplant unit. Transplantation 2014; 97:654-659.
Christensen SF, Hansen JM. Donor kidney with renal cell carcinoma successfully treated with radiofrequency ablation: a case report. Transplant Proc 2015 Dec; 47: 3031-3033.
Goeman L, Joniau S, Oyen R, van Poppel H. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy. Urology 2006; 67:199.e17-199.e19.
Veltri A, Grosso M, Castagneri F, et al. Radiofrequency thermal ablation of small tumors in transplanted kidneys: an evolving nephron-sparing option. J Vasc Interv Radiol 2009; 20:674-679.
Matevossian E, Novotny A, Vogelsang B, et al. Noninvasive therapy of incidental de novo renal cell carcinoma in a kidney allograft 12 years after transplantation: report of a case and review of literature. Transplant Proc 2008; 40:915-917.
Elkentaoui H, Robert G, Pasticier G, et al. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux. Urology 2010; 75:126-132.
Olivani A, Iaria M, Missale G, et al. Percutaneous ultrasound-guided radiofrequency ablation of an allograft renal cell carcinoma: a case report. Transplant Proc 2011; 43(10):3997-3999.
Chakera A, Leslie T, Roberts I, O'Callaghan CA, Cranston D. A lucky fall? Case report. Transplant Proc 2010; 42:3883-3886.
Zhou YF. High intensity focused ultrasound in clinical tumor ablation. World J Clin Oncol 2011;2:8-27.
Shah DR, Green S, Elliot A, McGahan J, Khatri V. Current oncologic applications of radiofrequency ablation therapies. World J Gastrointest Oncol 2013; 5:71-80.
Lynn JG, Zwemer RL, Chick AJ, Miller AE. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942; 26:179-193.
Burov AK. High-intensity ultrasonic vibrations for action on animal and human malignant tumours. Dokl Akad Nauk SSSR 106 1956; 2:239-241.
Al-Bataineh O, Jenne J, Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat Rev 2012; 38:346-353.
Chen B, Chen J, Luo Q, Guo C. Effective strategy of the combination of high-intensity focused ultrasound and transarterial chemoembolization for improving outcome of unresectable and metastatic hepatoblastoma: a retrospective cohort study. Transl Oncol 2014; 7:788-794.
Wang G, Zhou D. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: a report of 30 cases. Ultrason Sonochem 2015; 27:694-702.
Strunk HM, Henseler J, Rauch M, et al. Clinical use of high-intensity focused ultrasound (HIFU) for tumor and pain reduction in advanced pancreatic cancer. RoFo 2016; 188:662-670.
Ritchie RW, Leslie T, Phillips R, et al. Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow up. BJU Int 2010; 106:1004-1009.
Ritchie R, Collin J, Coussios C, Leslie T. Attenuation and de-focusing during high intensity focused ultrasound therapy through peri-nephric fat. Ultrasound Med Biol 2013; 39:1785-1793.
Singh I. Robot-assisted laparoscopic partial nephrectomy: current review of the technique and literature. J Minim Access Surg 2009; 5:87-92.
Morelli L, Morelli J, Palmeri M, et al. Robotic surgery and hemostatic agents in partial nephrectomy: a high rate of success without vascular clamping. J Robot Surg 2015; 9:215-222.
Ritchie RW, Leslie TA, Turner GD, et al. Laparoscopic high-intensity focused ultrasound for renal tumours: a proof of concept study. BJU Int 2011; 107:1290-1296.
Cornelis F, Buy X, André M, et al. De novo renal tumors arising in kidney transplants: midterm outcome after percutaneous thermal ablation. Radiology 2011; 260:900-907.
Cienfuegos-Belmonte I, León-Dueñas E, Pérez-Valdivia MA, Medina-López RA. Conservative treatment of de novo renal carcinoma on kidney graft. Actas Urol Esp 2015; 39:588-592.
Guleryuz K, Doerfler A, Codas R, et al. Renal Transplantation Committee of the French Urological Association (CTAFU). A national study of kidney graft tumor treatments: toward ablative therapy. Surgery 2016; 160:237-244.
González-López R, Bueno-Serrano G, Vázquez-Escuderos JJ, Mayor-De Castro J, González-Enguita C. Conservative treatment of renal cell carcinoma in kidney transplantation. Actas Urol Esp 2013; 37:242-248.